HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | 0.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,000 | -14.3% | 105 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $7,000 | 0.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | -41.7% | 105 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $12,000 | 0.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | +33.3% | 105 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,000 | 0.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $9,000 | -10.0% | 105 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $10,000 | -16.7% | 105 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,000 | -7.7% | 105 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $13,000 | 0.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $13,000 | +44.4% | 105 | 0.0% | 0.00% | +50.0% |
| Q1 2019 | $9,000 | -18.2% | 105 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $11,000 | -8.3% | 105 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $12,000 | +33.3% | 105 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $9,000 | +12.5% | 105 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $8,000 | +33.3% | 105 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $6,000 | +20.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | +25.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $4,000 | 0.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $4,000 | 0.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $4,000 | 0.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $4,000 | +33.3% | 105 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | +50.0% | 105 | +50.0% | 0.00% | +100.0% |
| Q1 2016 | $2,000 | -50.0% | 70 | -45.7% | 0.00% | -50.0% |
| Q4 2015 | $4,000 | 0.0% | 129 | +15.2% | 0.00% | -33.3% |
| Q3 2015 | $4,000 | -20.0% | 112 | -6.7% | 0.00% | 0.0% |
| Q2 2015 | $5,000 | 0.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $5,000 | +25.0% | 120 | +7.1% | 0.00% | 0.0% |
| Q4 2014 | $4,000 | 0.0% | 112 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $4,000 | 0.0% | 112 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $4,000 | 0.0% | 112 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $4,000 | – | 112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |